venBio Global Strategic Fund III, L.P.

Insider Reports History

Entity
Company
Location
1700 Owens Street, Suite 595, San Francisco, CA
Signature
venBio Global Strategic Fund III, L.P., by: venBio Global Strategic GP III, L.P., its general partner, by: venBio Global Strategic GP III, Ltd., its general partner, by: /s/ Antoinette Delhonte, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by venBio Global Strategic Fund III, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RayzeBio, Inc. 10%+ Owner Common Stock 5.16M $92.8M $18.00 Sep 19, 2023 Direct
Ventyx Biosciences, Inc. Other*, 10%+ Owner Common Stock 4M $8.47M $2.12 Oct 25, 2021 Direct
Ventyx Biosciences, Inc. Other*, 10%+ Owner Common Stock 1.01M $2.15M $2.12 Oct 25, 2021 Indirect
Elevation Oncology, Inc. 10%+ Owner Common Stock 1.91M $972K $0.51 May 25, 2022 Direct
Artiva Biotherapeutics, Inc. 10%+ Owner Common Stock 1.94M Jul 22, 2024 Direct
Ventyx Biosciences, Inc. Other*, 10%+ Owner Stock Option (right to buy) 13.3K Jun 9, 2022 Indirect
Artiva Biotherapeutics, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 Jul 22, 2024 Direct
Artiva Biotherapeutics, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 Jul 22, 2024 Direct
Elevation Oncology, Inc. 10%+ Owner Series B Preferred Stock 0 Jun 29, 2021 Direct
RayzeBio, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 Sep 19, 2023 Direct
RayzeBio, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 Sep 19, 2023 Direct
RayzeBio, Inc. 10%+ Owner Series C Convertible Preferred Stock 0 Sep 19, 2023 Direct
Ventyx Biosciences, Inc. Other*, 10%+ Owner Series A Preferred Stock 0 Oct 25, 2021 Direct
Ventyx Biosciences, Inc. Other*, 10%+ Owner Series B Preferred Stock 0 Oct 25, 2021 Direct

Insider Reports Filed by venBio Global Strategic Fund III, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ARTV Artiva Biotherapeutics, Inc. Jul 22, 2024 6 $5M 4 Jul 22, 2024 10%+ Owner
ARTV Artiva Biotherapeutics, Inc. Jul 18, 2024 0 $0 3 Jul 18, 2024 10%+ Owner
RYZB RayzeBio, Inc. Sep 19, 2023 6 $0 4 Sep 21, 2023 10%+ Owner
RYZB RayzeBio, Inc. Sep 14, 2023 0 $0 3 Sep 14, 2023 10%+ Owner
VTYX Ventyx Biosciences, Inc. Jun 9, 2022 2 $0 4 Jun 10, 2022 Other*, 10%+ Owner
ELEV Elevation Oncology, Inc. May 25, 2022 1 -$2.9M 4 May 27, 2022 10%+ Owner
VTYX Ventyx Biosciences, Inc. Oct 25, 2021 4 $5M 4 Oct 25, 2021 Other*, 10%+ Owner
VTYX Ventyx Biosciences, Inc. Oct 20, 2021 0 $0 3 Oct 20, 2021 Other*, 10%+ Owner
ELEV Elevation Oncology, Inc. Jun 29, 2021 3 $10M 4 Jul 1, 2021 10%+ Owner
ELEV Elevation Oncology, Inc. Jun 24, 2021 0 $0 3 Jun 24, 2021 10%+ Owner